FindTrial
Sign In

The imaging surveillance and survival study for breast cancer relapse and metastasis

The imaging surveillance and survival study for breast cancer relapse and metastasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17012559
Enrollment
Unknown
Registered
2017-09-03
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Relapse or Metastasis within first 3 year:observation
Replase or Metastasis at the 4- 5th year:observation
Replase or Metastasis after the 5th year:observation

Sponsors

The Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Breast cancer patients who succcessfuly completed breast conserving surgery (BCS) or mastectomy in Hebei Breast Care Center affilated with The Fourth Hospital of Hebei Medical University from medical records; (2) From Jan. 1, 2010 to Dec. 31, 2017, any new relapse or metastasis of breast cancer under the cateogory of the 'suspicious' or 'to be excluded' by any imaging (ultrasound, molybdenum target, CT, MRI, bone scan); (3) Had pathological report for breast cancer relapse.

Exclusion criteria

Exclusion criteria: (1) de novo stage IV breast cancer at first admission; (2) bilateral breast cancer.

Design outcomes

Primary

MeasureTime frame
Frequency of imagings used by Category & Year;Replase or Metastasis Pattern by Regions and Organs;Risk or Prognostic factors (all and by treament failures);survival and quality of life;—

Countries

China

Contacts

Public ContactZhensheng Li

Radiation Oncology Department, Fourth Hospital, Hebei Medical University

Zhensheng.Li.mdphd@gmail.com+86 15031101916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026